We identified PDIA1 as a major isoform of PDIs present in human breast cancer cells and lung microvascular endothelial cells and studied the effects of PDIA1 inhibitor, bepristat 2a and PDIA1 silencing on cancer–endothelium interactions and other functional aspects of the cancer cell phenotype. Here, P4HB is linked to breast cancer.